This topic contains a solution. Click here to go to the answer

Author Question: Who among the following is responsible for planning, implementing, and evaluating nutrition care ... (Read 34 times)

asmith134

  • Hero Member
  • *****
  • Posts: 576
Who among the following is responsible for planning, implementing, and evaluating nutrition care plans?
 a. Registered dieticians b. Dietetic technicians
  c. Nursing assistants d. Nurses

Question 2

Which of the following plays a major role in the breakdown of certain types of dietary fiber in the large intestine?
 a. Bacteria b. Pancreas
  c. Colonic cells d. Small intestinal villus cell



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

parshano

  • Sr. Member
  • ****
  • Posts: 333
Answer to Question 1

a

Answer to Question 2

a




asmith134

  • Member
  • Posts: 576
Reply 2 on: Aug 21, 2018
YES! Correct, THANKS for helping me on my review


amandanbreshears

  • Member
  • Posts: 320
Reply 3 on: Yesterday
Excellent

 

Did you know?

Atropine was named after the Greek goddess Atropos, the oldest and ugliest of the three sisters known as the Fates, who controlled the destiny of men.

Did you know?

Vital signs (blood pressure, temperature, pulse rate, respiration rate) should be taken before any drug administration. Patients should be informed not to use tobacco or caffeine at least 30 minutes before their appointment.

Did you know?

Disorders that may affect pharmacodynamics include genetic mutations, malnutrition, thyrotoxicosis, myasthenia gravis, Parkinson's disease, and certain forms of insulin-resistant diabetes mellitus.

Did you know?

The average person is easily confused by the terms pharmaceutics and pharmacology, thinking they are one and the same. Whereas pharmaceutics is the science of preparing and dispensing drugs (otherwise known as the science of pharmacy), pharmacology is the study of medications.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library